Home » Topics » BioWorld Science

BioWorld Science
RSS

Centogene collaborates with Aldeyra Therapeutics in Sjogren-Larsson syndrome

May 29, 2018

Wuhan Bowo Biological Technology divulges new influenza and RSV vaccines

May 29, 2018

Actavalon patents AhR agonists for cancer

May 29, 2018

New IDO-1 inhibitor PX-D26116 has improved metabolic stability compared to epacadostat

May 29, 2018

EMA accepts European filing for edaravone for ALS

May 29, 2018

Researchers present new antiviral compounds

May 29, 2018

Mouse model of VIPR2 gene copy number variation gives insight into neuropsychiatric disorders

May 29, 2018

Novel experimental model of ZIKV infection with pregnant common marmoset presented

May 29, 2018

Researchers present novel bifunctional mu-receptor agonist and NPFF receptor antagonist, KGFF-09

May 29, 2018

Prothena reorganizing resources to advance neuroscience pipeline

May 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...